{
    "Allocation": "Randomized",
    "CompleteTime": 48,
    "DesignModel": "Parallel Assignment",
    "DrugInformation": {
        "ArmGroupList": [
            {
                "ArmGroupDescription": "adebrelimab:   , bevacizumab:   , ",
                "ArmGroupLabel": "Adebrelimab in combination with Bevacizumab",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "adebrelimab",
                        "Duration": "",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "",
                        "DrugName": "bevacizumab",
                        "Duration": "",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Adebrelimab",
                        "Drug: Bevacizumab"
                    ]
                }
            },
            {
                "ArmGroupDescription": "adebrelimab:   , bevacizumab:   , shr-8068:   , ",
                "ArmGroupLabel": "Adebrelimab in combination with Bevacizumab and SHR-8068 RP2D1",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "adebrelimab",
                        "Duration": "",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "",
                        "DrugName": "bevacizumab",
                        "Duration": "",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "",
                        "DrugName": "shr-8068",
                        "Duration": "",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Adebrelimab",
                        "Drug: Bevacizumab",
                        "Drug: SHR-8068"
                    ]
                }
            },
            {
                "ArmGroupDescription": "adebrelimab:   , bevacizumab:   , shr-8068:   , ",
                "ArmGroupLabel": "Adebrelimab in combination with Bevacizumab and SHR-8068 RP2D2",
                "ArmGroupType": "Experimental",
                "InterventionDescription": [
                    {
                        "Dosage": "",
                        "DrugName": "adebrelimab",
                        "Duration": "",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "",
                        "DrugName": "bevacizumab",
                        "Duration": "",
                        "HowToTake": ""
                    },
                    {
                        "Dosage": "",
                        "DrugName": "shr-8068",
                        "Duration": "",
                        "HowToTake": ""
                    }
                ],
                "InterventionList": {
                    "ArmGroupInterventionName": [
                        "Drug: Adebrelimab",
                        "Drug: Bevacizumab",
                        "Drug: SHR-8068"
                    ]
                }
            }
        ]
    },
    "Enrollment": "129",
    "InterventionName": "adebrelimab, bevacizumab",
    "Masking": "None (Open Label)",
    "NCTID": "NCT05444088",
    "Objective": "Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma",
    "OfficialTitle": "An Open-label, Multicenter Phase Ib/II Clinical Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma",
    "PopulationBox": {
        "Condition": "Advanced Hepatocellular Carcinoma",
        "Gender": "All",
        "HealthyCondition": "No",
        "MaxAge": "75 Years",
        "MinAge": "18 Years",
        "Participant": "129"
    },
    "PopulationRatio": "",
    "Title": "Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular Carcinoma",
    "WashoutPeriod": ""
}